Serum leptin concentrations and fat redistribution in HIV-1-infected children on highly active antiretroviral therapy

HIV Medicine

Volumn 8, Issue 7, 2007, Pages 433-438

  Dzwonek, A B ^a,b   Novelli, V ^b   Schwenk, Achim ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Clinical Infectious Diseases Unit   (United Kingdom)

^c NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Antiretroviral agents adverse effects; Child; HIV associated lipodystrophy syndrome; Leptin

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHILD; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SIDE EFFECT; SKINFOLD THICKNESS; STATISTICAL MODEL;

ADIPOSE TISSUE; ADOLESCENT; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; FEMALE; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LEPTIN; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34548356421     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2007.00490.x     Document Type: Article

References (43)

1. May MT, Sterne JA, Costagliola D et al. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: A collaborative analysis. Lancet 2006; 368: 451-458.
2. Carr A, Samaras K, Chisholm DJ, Cooper DA. Abnormal fat distribution and use of protease inhibitors. Lancet 1998; 351: 1736.
3. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356: 1423-1430.
4. Nolan D, Mallal S. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome. J HIV Ther 2004; 9: 34-40.
5. Mallal SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 2000; 14: 1309-1316.
6. van der Valk M, Bisschop PH, Romijn JA et al. Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS 2001; 15: 2093-2100.
7. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antivir Ther 2004; 9: 161-177.
8. Lagathu C, Kim M, Maachi M et al. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo. Biochimie 2005; 87: 65-71.
9. Grunfeld C, Pang M, Shigenaga JK et al. Serum leptin levels in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1996; 81: 4342-4346.
10. Mantzoros CS. Leptin and the hypothalamus: Neuroendocrine regulation of food intake. Mol Psychiatry 1999; 4: 8-12.
11. Wauters M, Considine RV, Van Gaal LF. Human leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000; 143: 293-311.
12. Lonnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1995; 1: 950-953.
13. Considine RV, Caro JF. Leptin in humans: Current progress and future directions. Clin Chem 1996; 42: 843-844.
14. Fors H, Matsuoka H, Bosaeus I, Rosberg S, Wikland KA, Bjarnason R. Serum leptin levels correlate with growth hormone secretion and body fat in children. J Clin Endocrinol Metab 1999; 84: 3586-3590.
15. Savoye M, Dziura J, Castle J, DiPietro L, Tamborlane WV, Caprio S. Importance of plasma leptin in predicting future weight gain in obese children: A two-and-a-half-year longitudinal study. Int J Obes Relat Metab Disord 2002; 26: 942-946.
16. Nagy GS, Tsiodras S, Martin LD et al. Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin. Clin Infect Dis 2003; 36: 795-802.
17. Johnson JA, Albu JB, Engelson ES et al. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab 2004; 286: E261-E271.
18. Wunder D, Bersinger NA, Fux C et al. Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS 2005; 19: 1837-1842.
19. Krause JC, Toye MP, Stechenberg BW, Reiter EO, Allen HF. HIV-associated lipodystrophy in children. Pediatr Endocrinol Rev 2005; 3: 45-51.
20. Verkauskiene R, Dollfus C, Levine M et al. Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome. Pediatr Res 2006; 60: 225-230.
21. Dzwonek AB, Lawson MS, Cole TJ, Novelli V. Body fat changes and lipodystrophy in HIV-infected children: Impact of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 121-123.
22. Centers for Disease Control. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morbidity and Mortality Weekly Report 1994; 43 (RR-12): 1-10.
23. Sharland M, Blanche S, Castelli G, Ramos J, Gibb DM. PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med 2004; 5 (Suppl. 2): 61-86.
24. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004; 18: 1443-1451.
25. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25-29.
26. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73: 17-24.
27. Gerver WJ, Bruin R. Paediatric Morphometrics. A Reference Manual, 2nd edn. Maastricht, The Netherlands: Universitaire Pers Maastricht, 2001.
28. Dzwonek AB, Novelli V, Lawson MS. Body fat changes and lipodystrophy in HIV-infected children: Impact of HAART. 7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Dublin, Ireland, November 2005. Antiviral Ther 2005; 10: L22.
29. Danadian K, Suprasongsin C, Janosky JE, Arslanian S. Leptin in African-American children. J Pediatr Endocrinol Metab 1999; 12: 639-644.
30. Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. Model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 1999; 69: 584-596.
31. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001; 15: 2565-2571.
32. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: E827-E847.
33. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531-543.
34. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76.
35. Oral EA, Ruiz E, Andewelt A et al. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 2002; 87: 3110-3117.
36. Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R. Adipocyte-derived hormone levels in HIV lipodystrophy. Antiviral Ther 2003; 8: 9-15.
37. Bessesen DH, Faggioni R. Recently identified peptides involved in the regulation of body weight. Semin Oncol 1998; 25: 28-32.
38. Schwenk A, Hodgson L, Rayner CF, Griffin GE, Macallan DC. Leptin and energy metabolism in pulmonary tuberculosis. Am J Clin Nutr 2003; 77: 392-398.
39. Considine RV. Weight regulation, leptin and growth hormone. Horm Res 1997; 48 (Suppl. 5): 116-121.
40. Christeff N, Melchior JC, De Truchis P, Perronne C, Gougeon ML. Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome. Eur J Clin Invest 2002; 32: 43-50.
41. Lihn AS, Richelsen B, Pedersen SB et al. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: Implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab 2003; 285: E1072-E1080.
42. Haugaard SB, Andersen O, Pedersen SB et al. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. Metabolism 2006; 55: 175-182.
43. Vigano A, Mora S, Brambilla P et al. Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents. AIDS 2003; 17: 1435-1441.